VCRAX
Price
$14.23
Change
+$0.13 (+0.92%)
Updated
Jul 9 closing price
Net Assets
905.9M
VCRCX
Price
$14.16
Change
+$0.12 (+0.85%)
Updated
Jul 9 closing price
Net Assets
913.91M
Interact to see
Advertisement

VCRAX vs VCRCX

Header iconVCRAX vs VCRCX Comparison
Open Charts VCRAX vs VCRCXBanner chart's image
NYLI CBRE Global Infrastructure
Price$14.23
Change+$0.13 (+0.92%)
VolumeN/A
Net Assets905.9M
NYLI CBRE Global Infrastructure
Price$14.16
Change+$0.12 (+0.85%)
VolumeN/A
Net Assets913.91M
VCRAX vs VCRCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VCRAX vs. VCRCX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCRAX is a Buy and VCRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCRCX (914M) and VCRAX (906M) have equal amount of cash in the bank . VCRAX pays higher dividends than VCRCX: VCRAX (1.83) vs VCRCX (1.02). VCRAX was incepted earlier than VCRCX: VCRAX (12 years) vs VCRCX (6 years). VCRCX (2.10) is less costly to investors than VCRAX (1.28). VCRAX (47.00) and VCRCX (47.00) have comparable annual turnover. VCRCX has a lower initial minimum investment than VCRAX: VCRCX (1000) vs VCRAX (15000). VCRAX annual gain was more profitable for investors over the last year : 18.47 vs. VCRCX (17.38). VCRAX return over 5 years is better than : 41.85 vs. VCRCX (36.57).
VCRAXVCRCXVCRAX / VCRCX
Total Expense Ratio1.282.0862%
Annual Report Gross Expense Ratio1.282.1061%
Fund Existence12 years6 years-
Gain YTD10.2389.740105%
Front Load6%N/A-
Min. Initial Investment1500010001,500%
Min. Initial Investment IRAN/AN/A-
Net Assets906M914M99%
Annual Yield % from dividends1.831.02180%
Returns for 1 year18.4717.38106%
Returns for 3 years21.3318.34116%
Returns for 5 years41.8536.57114%
Returns for 10 years49.71N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNDA5.020.16
+3.29%
Vanda Pharmaceuticals
ACRV1.340.03
+2.29%
Acrivon Therapeutics
LPX90.500.59
+0.66%
Louisiana-Pacific Corp
SYK392.052.55
+0.65%
Stryker Corp
ACDC7.52-0.37
-4.69%
ProFrac Holding Corp